Streetbeat News

Price Targets

TMDX

Piper Sandler analyst Matt O'Brien initiates coverage on TransMedics Gr (NASDAQ:TMDX) with an Overweight rating and a price target of $95.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:06 am

PPTA

HC Wainwright & Co. analyst Heiko Ihle maintains a Buy rating on Perpetua Resources (NASDAQ:PPTA) and raises the price target from $10 to $10.5.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:05 am

SLE

HC Wainwright & Co. analyst Scott Buck has reiterated a Buy rating on Super League Enterprise (NASDAQ:SLE) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:02 am

EL

Estee Lauder's stock price increased following an upgrade from B of A Securities, moving from Neutral to Buy, with a new price target set at $170, up from $160.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:02 am

AQMS

HC Wainwright & Co. analyst Amit Dayal reiterated a Buy rating on Aqua Metals (NASDAQ:AQMS) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:00 am

REE

HC Wainwright & Co. analyst Amit Dayal has reiterated a Buy rating on REE Automotive (NASDAQ:REE), maintaining a $15 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:52 am

XERS

Oppenheimer analyst Leland Gershell initiates coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with an Outperform rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:51 am

IMVT

Oppenheimer analyst Leland Gershell initiates coverage on Immunovant (NASDAQ:IMVT) with an Outperform rating and a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:49 am

VRNT

Needham analyst Joshua Reilly has reiterated a Buy rating on Verint Systems (NASDAQ:VRNT) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:49 am

VNO

Morgan Stanley analyst Ronald Kamdem upgraded Vornado Realty (VNO) from Underweight to Equal-Weight and increased the price target from $24 to $26.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:46 am